Early viral kinetics do not predict treatment outcome with sofosbuvir+ribavirin for 12 or 24 weeks in HCV genotype 2/3 patients in the valence trial

Autor:	Norbert H. Grüner, M.P. Manns, J Schulze-zur-Wiesch, Diana M. Brainard, Ulrich Spengler, Dietrich Hüppe, Jörg Petersen, L Gallo, John G. McHutchison, N Forestier, S. Zeuzem, Dieter Häussinger, Martin Rössle, Thomas Berg, W Symonds, Stefan Christensen, Holger Hinrichsen, Christoph Eisenbach, T Warger, Renate Heyne
Rok vydání:	2014
Předmět:	Valence (chemistry) Sofosbuvir business.industry Ribavirin Treatment outcome Gastroenterology Viral kinetics Virology chemistry.chemical_compound chemistry Genotype Medicine business medicine.drug
Zdroj:	Zeitschrift für Gastroenterologie. 52
ISSN:	1439-7803 0044-2771
DOI:	10.1055/s-0034-1386163
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::73d8cb056ebc9ae3d9bc00a7b0d4964d https://doi.org/10.1055/s-0034-1386163 Zobrazit plný text záznamu